Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Biosimilars Deals 2023
Biosimilars Deals 2024
Chris Vindurampulle
Other Podcasts
Other Updates
Our Awards
Patent Case Summaries
Patent Litigation
Paul Johns
Trade Marks

Novo Nordisk Announces US$4.1B Investment to Expand US Manufacturing Capacity

Jun 25, 2024

On 25 June 2024, Novo Nordisk announced its plan to significantly boost its investment in manufacturing in 2024, allocating USD $6.8 billion towards production.  This is up from USD $3.9 billion the previous year.  

The plan includes a USD $4.1 billion investment to build a second manufacturing facility in Clayton, North Carolina, expanding its capacity to produce injectable treatments for obesity and chronic diseases. The new facility will add 1.4 million square feet of production space and create 1,000 new jobs.  

This news follows Ginkgo Bioworks’ announcement on 10 April 2024 of an expansion of its partnership with global healthcare leader, Novo Nordisk.